Document is current
Any future updates will be listed below
-
Authors
Mühleck, Regina
Scholl, Sebastian
Hilgendorf, Inken
Schrenk, Karin
Hammersen, Jakob
Frietsch, Jochen J.
Fleischmann, Maximilian
Sayer, Herbert G.
Glaser, Anita
Hochhaus, Andreas
Schnetzke, Ulf https://orcid.org/0000-0001-7455-8988
-
Funding
Funding for this research was provided by:
Universitätsklinikum Jena
- License Information
-
More Information
Article History
Received: 20 August 2021
Accepted: 25 September 2021
First Online: 5 October 2021
Declarations
:
: The authors declare no conflict of interest.
: Informed consent of patients for participation was obtained when registered for either the OSHO or SAL registry (see above).
: Consent of patients to publish was obtained when registered for either the OSHO or SAL registry (see above).
: This data analysis was approved by the local Ethics committee of the University Hospital Jena, Germany (Ethical numbers 4871-07/16 for “retrospective evaluation of therapy response and survival in patients with AML” and 3967-12/13 for SAL registry).
